Skip to main content

Mycapssa

NDC 69880-120 · Amryt Pharmaceuticals Designated Activity Company

Generic nameOctreotide
Dosage formCAPSULE, DELAYED RELEASE
RouteORAL
Active ingredient(s)OCTREOTIDE
Strength20 mg/1
Pharmacologic classSomatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
Marketing categoryNDA

Packages

69880-120-28 — 4 BLISTER PACK in 1 DOSE PACK (69880-120-28) / 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

10122-550 — Octreotide

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T38.991 — Poisoning by other hormone antagonists, accidental (unintentional), T38.992 — Poisoning by other hormone antagonists, intentional self-harm, T38.993 — Poisoning by other hormone antagonists, assault, T38.994 — Poisoning by other hormone antagonists, undetermined, T38.995 — Adverse effect of other hormone antagonists, T38.996 — Underdosing of other hormone antagonists

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.